In 20 years cell and gene therapies for cancer will be commonplace
Sep 6, 2021 ·
41m 30s
Download and listen anywhere
Download your favorite episodes and enjoy them, wherever you are! Sign up or log in now to access offline listening.
Description
Cancer is one of the world’s most devastating diseases. Its treatment can be punishing, and have several nasty side effects. Fortunately, scientists have a better idea now of how to...
show more
Cancer is one of the world’s most devastating diseases. Its treatment can be punishing, and have several nasty side effects. Fortunately, scientists have a better idea now of how to treat it, and the experimental techniques being used now may be commonplace in the future. At least, that’s what many experts think.
Host Rudy van Beurden has invited three guests who are experts in this field: Jacqueline Barry, Chief Clinical Officer at CT Catapult; Erik Manting, CEO at Immunicum AB and Trudy Straetemans, Assistant Professor at UMC Utrecht.
Do you want to learn more about these speakers or this podcast? Check out kadans.com/podcast.kadans, cancer, cell therapy, gene therapy, disease, experimental
Building the Future is brought to you by Kadans Science Partner.
show less
Host Rudy van Beurden has invited three guests who are experts in this field: Jacqueline Barry, Chief Clinical Officer at CT Catapult; Erik Manting, CEO at Immunicum AB and Trudy Straetemans, Assistant Professor at UMC Utrecht.
Do you want to learn more about these speakers or this podcast? Check out kadans.com/podcast.kadans, cancer, cell therapy, gene therapy, disease, experimental
Building the Future is brought to you by Kadans Science Partner.
Information
| Author | Airborne |
| Organization | Airborne Audio (NL) |
| Website | - |
| Tags |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
Comments